v3.26.3
Note 13 - Segment Reporting and Geographic Information (Tables)
9 Months Ended
Sep. 30, 2026
Notes Tables  
Segment Reporting, Reconciliation of Other Item by Segment to Consolidated [Table Text Block]
   

Three months ended September 30,

   

Nine months ended September 30,

 
   

2025

   

2026

   

2025

   

2026

 
     

$

     

$

     

$

     

$

 
   

(unaudited)

   

(unaudited)

   

(unaudited)

   

(unaudited)

 

Clinical and pre-clinical expenses

    428       676       720       1,742  

Patent expenses

    169       92       644       302  

Personnel costs

    562       512       2,148       1,662  

Professional services

    233       569       1,587       1,398  

Other operational expenses

    248       214       756       641  

Other segment items

    (18 )     1       (69 )     (9 )

Segment net loss

    1,622       2,064       5,786       5,736  

Reconciliation of net loss (income):

                               

Net loss (income) from discontinued operations

    3,322       (52,556 )     2,637       (43,854 )

Net loss (income)

    4,944       (50,492 )     8,423       (38,118 )
Segment Reporting, Entity-Wide Information Not Provided as Part of Reportable Segment, Geographical Area, Long-Lived Asset [Table Text Block]
   

As of

 
   

December 31, 2025

   

September 30, 2026

 
     

$

     

$

 

 

         

(unaudited)

 
Property and equipment, net:              
                 

U.S.

    155       117  
                 

Total

    155       117